branch retinal vein occlusion
Conditions
Interventions
Sponsors
Eligibility
Inclusion criteria
Inclusion criteria: Patient of branch retinal vein occlusion with cystoid macular edema Onset within 1 year Hope of treatment Willingness to provide written informed consent
Exclusion criteria
Exclusion criteria: Target eye: Prior treatment with anti-VEGF drug and steroid drug Prior treatment with intraocular surgery (<3 months) Another diseases to decrease visual acuity Prior treatment with vitrectomy Fellow eye is already enrolled in the study (If already both eyes onset, the eye which has wider occlusion area is enrolled.) Prior history of brain cardiovascular evebts Patient who the doctor in charge judges are ineligible for the study
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Visual acuity and central macular thickness at month 12 after initial injection of aflibercept | — |
Secondary
| Measure | Time frame |
|---|---|
| Visual acuity and central macular thickness at month 24 after initial injection of aflibercept | — |
Countries
Japan
Contacts
Jichi Medical University Department of Ophthalmology